Maitreya Medicare Ltd

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 16 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 June 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 21 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 10 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and technical outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 26 March 2026, providing investors with the latest insights into its performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 March 2026, providing investors with the latest insights into its performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis below reflects the stock’s current position as of 08 February 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Maitreya Medicare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insight into the company’s performance and outlook.

Maitreya Medica., a microcap player in the hospital sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance from market analysts.